This card is part of the marketing authorisation for Opdualag (nivolumab and relatlimab) and contains important safety information that you need to be aware of. Please also ensure that you carry this card with you at all times to inform any healthcare professional treating you (e.g., emergency department personnel) that you are receiving treatment with nivolumab and relatlimab. This Patient Card was last updated in August 2025 (administrative updates only).